ARCHIVES

In Brief: Bioassay Prime Contract Renewed For Four Years, $34.2 Million; Canellos Quits As Clinical Director

This article is from The Cancer Letter archive.

Vol. 01 No. 25 | June 20, 1975

Download PDF Visit The Full Archive

Related Articles

NIH director; Targets Increases Favor Established Researchers

May 9, 1997

Scientists Glimpse Cellular Machines Inside Living Cells; Funding Opportunities

November 22, 2002

Army Hopes To Fund “Middle-Risk, high Payoff” Research With Breast Cancer money. Travis Says

February 19, 1993

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014

Greenberg: More Work Needs to be Done

November 7, 2014

Drug Combination Tested For B.C. Brain Metastases

January 25, 2008